Level Four Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-500
Closed -$1.88K – 760
2023
Q2
$1.88K Buy
+500
New +$73.3K ﹤0.01% 800

Other funds holding ABBV

Level Four Advisory Services's ABBV Position: Q2 2026 in Review

Level Four Advisory Services increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $627K and bringing the position to 135,146 shares worth $34M. The position accounts for 0.96% of the portfolio, ranked #14.

Level Four Advisory Services first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $35.4M in Q1 2023. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Level Four Advisory Services held 135,146 shares of AbbVie worth $34M as of Q2 2026.
  • Level Four Advisory Services bought 2,912 AbbVie shares in Q2 2026, an estimated $627K.
  • AbbVie made up 0.96% of Level Four Advisory Services's portfolio in Q2 2026, its #14 holding.
  • Level Four Advisory Services first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
  • Level Four Advisory Services's AbbVie position peaked at $35.4M in Q1 2023.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.